- Home
- AMZN vs TMO Comparison
AMZN vs TMO Comparison
Compare AMZN & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMZN | TMO |
|---|---|---|
| Founded | 1994 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6T | 164.3B |
| IPO Year | 1997 | 1996 |
Fundamental Metrics
Financial Performance| Metric | AMZN | TMO |
|---|---|---|
| Price | $234.41 | $469.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 42 | 18 |
| Target Price | $285.88 | ★ $636.00 |
| AVG Volume (30 Days) | ★ 39.4M | 2.2M |
| Earning Date | 04-29-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.40% |
| EPS Growth | ★ 29.66 | 7.32 |
| EPS | 2.78 | ★ 4.43 |
| Revenue | ★ $716,924,000,000.00 | $20,918,000,000.00 |
| Revenue This Year | $14.63 | $6.55 |
| Revenue Next Year | $11.81 | $5.11 |
| P/E Ratio | ★ $83.82 | $104.74 |
| Revenue Growth | 12.38 | ★ 14.47 |
| 52 Week Low | $196.00 | $398.08 |
| 52 Week High | $278.56 | $643.99 |
Technical Indicators
Market Signals| Indicator | AMZN | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 39.09 | 48.17 |
| Support Level | $225.96 | $456.87 |
| Resistance Level | $238.97 | $494.30 |
| Average True Range (ATR) | 7.68 | 11.94 |
| MACD | -1.60 | -1.13 |
| Stochastic Oscillator | 13.51 | 27.86 |
Price Performance
Historical ComparisonAbout AMZN Amazon.com Inc.
Amazon is the leading online retailer and marketplace for third party sellers. Retail related revenue represents approximately 74% of total, followed by Amazon Web Services (17%), and advertising services (9%). International segments constitute 22% of Amazon's total revenue, led by Germany, the United Kingdom, and Japan.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).